my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
CellGenix is a leading global supplier of high quality reagents and tools in the expanding markets of cell and gene therapy and regenerative medicine. CellGenix’ product portfolio includes growth factors, cytokines, serum-free media as well as closed cell culture systems (EU only). The products are more
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Since 1989, we have developed innovative and reliable technologies for scientists and clinicians around the world. Our integrated portfolio of tools covers techniques of sample prepar more
Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. more
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia. However, the side effects of therapies are often severe. A group of researchers led by the University of Zurich have now shown how human healthy and cancerous hematopoietic stem cells can be more selective more
With one of the most comprehensive life sciences ecosystems in the world, Swiss biotech continues to thrive. The 2020 edition of the Swiss Biotech Report launched by the Swiss Biotech Association in conjunction with EY and seven other partners, provides highlights and analysis of funding, M&A and co more
MicrofluidX announcesdit has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its novel cell bioprocessing technolo more
The global landscape of cancer cell therapy The global landscape of cancer cell therapy, Published online: 25 May 2018; doi:10.1038/nrd.2018.74 How many cancer cell therapies are being developed? To harmonize efforts in this arena, the Cancer Research Institute has curated a database that includes more
Despite recent advances in reducing therapy-related mortality after allogeneic stem cell transplantation (alloSCT) relapse remains the major cause of treatment failure and little progress has been achieved in the last decades. At the 3rd International Workshop on Biology, Prevention, and Treatment o more
The effects of cell therapy on heart regeneration in patients with chronic cardiomyopathy have been assessed in several clinical trials. These trials can be categorized as those using noncardiac stem cells, including mesenchymal stem cells, and those using cardiac-committed cells, including KIT+ car more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2020 LUMITOS AG, All rights reserved
